Search

Search Constraints

You searched for: Author/Creator Ninomiya, Takashi

Search Results

1. A phase I trial of afatinib and bevacizumab in chemo-naïve patients with advanced non-small-cell lung cancer harboring EGFR mutations: Okayama Lung Cancer Study Group Trial 1404. (January 2018)

3. Combined effect of cabozantinib and gefitinib in crizotinib‐resistant lung tumors harboring ROS1 fusions. Issue 10 (11th September 2018)

4. Early administration of durvalumab after chemoradiotherapy increased risk of pneumonitis in patients with locally advanced non‐small cell lung cancer. Issue 2 (10th June 2022)

5. Immune checkpoint inhibitor efficacy and safety in older non-small cell lung cancer patients. (1st September 2020)

6. Lower gefitinib dose led to earlier resistance acquisition before emergence of T790M mutation in epidermal growth factor receptor‐mutated lung cancer model. Issue 11 (25th October 2013)

7. Multicentre real-world data of ramucirumab plus docetaxel after combined platinum-based chemotherapy with programmed death-1 blockade in advanced non-small cell lung cancer: NEJ051 (REACTIVE study). (May 2023)

9. Patients' preferences and perceptions of lung cancer treatment decision making: results from Okayama lung cancer study group trial 1406. (3rd March 2020)

10. Phase II study of nab‐paclitaxel + carboplatin for patients with non‐small‐cell lung cancer and interstitial lung disease. Issue 12 (6th November 2019)